These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12069975)

  • 1. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.
    Malbruny B; Canu A; Bozdogan B; Fantin B; Zarrouk V; Dutka-Malen S; Feger C; Leclercq R
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2200-7. PubMed ID: 12069975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B; Leclercq R
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.
    Pereyre S; Guyot C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Feb; 48(2):460-5. PubMed ID: 14742195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Fantin B; Leclercq R; Merlé Y; Saint-Julien L; Veyrat C; Duval J; Carbon C
    Antimicrob Agents Chemother; 1995 Feb; 39(2):400-5. PubMed ID: 7726505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
    Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program.
    Jones RN; Farrell DJ; Morrissey I
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2696-8. PubMed ID: 12878545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2000 May; 44(5):1168-73. PubMed ID: 10770747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.
    Cattoir V; Merabet L; Legrand P; Soussy CJ; Leclercq R
    J Antimicrob Chemother; 2007 May; 59(5):1010-2. PubMed ID: 17434877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus].
    Matsuoka M
    Yakugaku Zasshi; 2000 Apr; 120(4):374-86. PubMed ID: 10774259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator.
    Fuchs PC; Barry AL; Brown SD
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2880-2. PubMed ID: 10991879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
    Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
    Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.
    Harms JM; Schlünzen F; Fucini P; Bartels H; Yonath A
    BMC Biol; 2004 Apr; 2():4. PubMed ID: 15059283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin.
    Schmitz FJ; Sadurski R; Stattfeld A; Kray A; Verhoef J; Fluit AC
    J Antimicrob Chemother; 1999 Dec; 44(6):847-9. PubMed ID: 10590291
    [No Abstract]   [Full Text] [Related]  

  • 20. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin.
    Davydova N; Streltsov V; Wilce M; Liljas A; Garber M
    J Mol Biol; 2002 Sep; 322(3):635-44. PubMed ID: 12225755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.